Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorGENARO, Isabella Santos de-
dc.contributor.authorALMEIDA, Francine Maria de-
dc.contributor.authorHIZUME-KUNZLER, Deborah Camargo-
dc.contributor.authorMORIYA, Henrique Takachi-
dc.contributor.authorSILVA, Ronaldo Aparecido-
dc.contributor.authorCRUZ, Joao Carlos Goncalves-
dc.contributor.authorLOPES, Renan Boeira-
dc.contributor.authorRIGHETTI, Renato Fraga-
dc.contributor.authorVIEIRA, Rodolfo de Paula-
dc.contributor.authorSAIKI, Mitiko-
dc.contributor.authorMARTINS, Milton Arruda-
dc.contributor.authorTIBERIO, Iolanda de Fatima Lopes Calvo-
dc.contributor.authorARANTES-COSTA, Fernanda Magalhaes-
dc.contributor.authorSARAIVA-ROMANHOLO, Beatriz Mangueira-
dc.identifier.citationSCIENTIFIC REPORTS, v.8, article ID 12636, 13p, 2018-
dc.description.abstractWork-exacerbated asthma (WEA) is defined as preexisting asthma that worsens with exposure to irritants [e.g., chlorine (Cl-2) derivatives] in the workplace. The maximum allowable concentration in the workplace of Cl-2 exposure is 3 mg/m(3) (described in OSHA). We investigated in an experimental asthma model in mice the effects of a single exposure to a sodium hypochlorite dose with this allowed chlorine concentration and a tenfold higher dose. Acute chlorine exposure at 3.3 mg/m(3) in the OVA-sensitized group increased eosinophils in the peribronquial infiltrate, cytokine production, nasal mucus production and the number of iNOS positive cells in the distal lung compared to only sensitized mice. The exposure to a higher dose of 33.3 mg/m(3) in the OVA-sensitized group resulted in an increase in respiratory system elastance, in the total and differential numbers of inflammatory cells in bronchoalveolar lavage fluid, IL-4, IL-5, and IL-17 in the lungs, eosinophils in peribronquial infiltrate and mucus content in nasal compared to non-exposed and sensitized animals. In this asthma model, chorine exposures at an allowable dose, contributed to the potentiation of Th2 responses. The functional alterations were associated with increased iNOS and ROCK-2 activation in the distal lung.-
dc.description.sponsorshipSao Paulo Research Foundation, (FAPESP) [2009/53904-9, 2012/15165-2]-
dc.description.sponsorshipExperimental Therapeutic Laboratory I, School of Medicine, University of Sao Paulo, School of Medicine Foundation (FFM/USP) [LIM 20]-
dc.description.sponsorshipAUXPE/PROAP [2696/2013]-
dc.relation.ispartofScientific Reports-
dc.subject.otherdiesel exhaust particles-
dc.subject.otherairway epithelial-cells-
dc.subject.otherrho-kinase inhibition-
dc.subject.othernitric-oxide synthase-
dc.subject.otheroccupational asthma-
dc.subject.otherlung inflammation-
dc.subject.otherstereological methods-
dc.subject.otherconsensus statement-
dc.titleLow dose of chlorine exposure exacerbates nasal and pulmonary allergic inflammation in mice-
dc.rights.holderCopyright NATURE PUBLISHING GROUP-
dc.subject.wosMultidisciplinary Sciences-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-, Isabella Santos de:Publ Employee Sao Paulo Hosp IAMSPE, Sao Paulo, Brazil; Univ Sao Paulo, Sch Med, Dept Med LIM 20, Sao Paulo, Brazil-, Henrique Takachi:Univ Sao Paulo, Escola Politecn, Biomed Engn Lab, Sao Paulo, Brazil-, Joao Carlos Goncalves:Univ City Sao Paulo UNICID, Sao Paulo, Brazil-, Renan Boeira:Univ City Sao Paulo UNICID, Sao Paulo, Brazil-, Rodolfo de Paula:Univ Brasil, Postgrad Program Bioengn, Sao Paulo, Brazil; Brazilian Inst Teaching & Res Pulm & Exercise Imm, Sao Jose Dos Campos, Brazil-, Mitiko:IPEN CNEN SP, Nucl & Energy Res Inst, Sao Paulo, Brazil-
hcfmusp.relation.referenceAdler A, 2004, J APPL PHYSIOL, V97, P286, DOI 10.1152/japplphysiol.00821.2003-
hcfmusp.relation.reference[Anonymous], 2011, NATL RES COUNCIL NAT-
hcfmusp.relation.reference[Anonymous], 2010, OCC ASTHM ID MAN PRE-
hcfmusp.relation.referenceArantes-Costa FM, 2008, TOXICOL PATHOL, V36, P680, DOI 10.1177/0192623308317427-
hcfmusp.relation.referenceAvila LCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137273-
hcfmusp.relation.referenceBello A, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-76-
hcfmusp.relation.referenceBerger Z, 2006, J OCCUP ENVIRON MED, V48, P833, DOI 10.1097/01.jom.0000225169.45337.97-
hcfmusp.relation.referenceBernard A, 2007, CURR MED CHEM, V14, P1771-
hcfmusp.relation.referenceBruggemann T R, 2015, Int J Sports Med, V36, pe10, DOI 10.1055/s-0035-1549904-
hcfmusp.relation.referenceCamargo LD, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01835-
hcfmusp.relation.referenceCao D, 2007, AM J PHYSIOL-LUNG C, V292, pL422, DOI 10.1152/ajplung.00204.2006-
hcfmusp.relation.referenceCartier A, 2011, IMMUNOL ALLERGY CLIN, V31, P717, DOI 10.1016/j.iac.2011.07.005-
hcfmusp.relation.referenceChaudhuri N, 2010, AM J PHYSIOL-LUNG C, V299, pL263, DOI 10.1152/ajplung.00297.2009-
hcfmusp.relation.referenceCowl CT, 2011, CHEST, V139, P674, DOI 10.1378/chest.10-0079-
hcfmusp.relation.referenceCRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148-
hcfmusp.relation.referenceDAHLEN B, 1995, CLIN EXP ALLERGY, V25, P50, DOI 10.1111/j.1365-2222.1995.tb00422.x-
hcfmusp.relation.referenceDe Soete D., 1972, NEUTRON ACTIVATION A-
hcfmusp.relation.referenceDESCHAMPS D, 1994, CHEST, V105, P1895, DOI 10.1378/chest.105.6.1895-
hcfmusp.relation.referenceErle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050-
hcfmusp.relation.referenceFahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061-
hcfmusp.relation.referenceFishwick D, 2012, THORAX, V67, P278, DOI 10.1136/thoraxjnl-2011-200755-
hcfmusp.relation.referenceFLISS H, 1988, MOL CELL BIOCHEM, V84, P177, DOI 10.1007/BF00421053-
hcfmusp.relation.referenceGoe SK, 2004, OCCUP ENVIRON MED, V61, P512, DOI 10.1136/oem.2003.008177-
hcfmusp.relation.referenceGorguner M, 2004, INHAL TOXICOL, V16, P87, DOI 10.1080/08958370490265004-
hcfmusp.relation.referenceHalonen JI, 2008, THORAX, V63, P635, DOI 10.1136/thx.2007.091371-
hcfmusp.relation.referenceHammerschmidt S, 2004, BBA-MOL BASIS DIS, V1690, P258, DOI 10.1016/j.bbadis.2004.07.003-
hcfmusp.relation.referenceHelenius IJ, 1998, ALLERGY, V53, P346, DOI 10.1111/j.1398-9995.1998.tb03904.x-
hcfmusp.relation.referenceHenneberger PK, 2011, AM J RESP CRIT CARE, V184, P368, DOI 10.1164/rccm.812011ST-
hcfmusp.relation.referenceHERBERT RA, 1999, PATHOLOGY MOUSE REFE, P259-
hcfmusp.relation.referenceHewitt M, 2010, AM J RESP CELL MOL, V42, P243, DOI 10.1165/rcmb.2009-0038OC-
hcfmusp.relation.referenceHiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514-
hcfmusp.relation.referenceHizume DC, 2012, RESP PHYSIOL NEUROBI, V181, P167, DOI 10.1016/j.resp.2012.03.005-
hcfmusp.relation.referenceHox V, 2011, TOXICOL LETT, V204, P101, DOI 10.1016/j.toxlet.2011.04.017-
hcfmusp.relation.referenceJAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242-
hcfmusp.relation.referenceJares EJ, 2012, CURR ALLERGY ASTHM R, V12, P221, DOI 10.1007/s11882-012-0259-2-
hcfmusp.relation.referenceJONES R, 1978, LAB INVEST, V39, P41-
hcfmusp.relation.referenceKenyon NJ, 2012, CLIN REV ALLERG IMMU, V43, P3, DOI 10.1007/s12016-011-8272-0-
hcfmusp.relation.referenceKim SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106861-
hcfmusp.relation.referenceKiss T, 2016, BRIT J ANAESTH, V116, P708, DOI 10.1093/bja/aew093-
hcfmusp.relation.referenceLangdeau JB, 2000, AM J RESP CRIT CARE, V161, P1479, DOI 10.1164/ajrccm.161.5.9909008-
hcfmusp.relation.referenceLemiere C., 2016, REACTIVE AIRWAYS DYS-
hcfmusp.relation.referenceLEMOS M, 1994, ENVIRON RES, V66, P87, DOI 10.1006/enrs.1994.1046-
hcfmusp.relation.referenceLeppanen T, 2014, BASIC CLIN PHARMACOL, V114, P37, DOI 10.1111/bcpt.12139-
hcfmusp.relation.referenceLourenco JD, 2018, HISTOL HISTOPATHOL, V33, P289, DOI 10.14670/HH-11-927-
hcfmusp.relation.referenceMartin JG, 2003, AM J RESP CRIT CARE, V168, P568, DOI 10.1164/rccm.200201-021OC-
hcfmusp.relation.referenceMartins-Olivera BT, 2016, MEDIAT INFLAMM, DOI 10.1155/2016/5346574-
hcfmusp.relation.referenceMedina-Ramon M, 2005, OCCUP ENVIRON MED, V62, P598, DOI 10.1136/oem.2004.017640-
hcfmusp.relation.referenceOByrne PM, 1997, CHEST, V111, pS27, DOI 10.1378/chest.111.2_Supplement.27S-
hcfmusp.relation.referencePark EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026749-
hcfmusp.relation.referenceParker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT-
hcfmusp.relation.referencePatel H, 2011, TOXICOL LETT, V200, P124, DOI 10.1016/j.toxlet.2010.11.007-
hcfmusp.relation.referencePautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007-
hcfmusp.relation.referencePawankar R., 2013, WORLD ALLERGY ORG W-
hcfmusp.relation.referencePigati PA, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0073-4-
hcfmusp.relation.referencePossa SS, 2012, AM J PHYSIOL-LUNG C, V303, pL939, DOI 10.1152/ajplung.00034.2012-
hcfmusp.relation.referencePrado Carla M, 2011, ISRN Allergy, V2011, P832560, DOI 10.5402/2011/832560-
hcfmusp.relation.referenceProkopowicz ZM, 2010, J IMMUNOL, V184, P824, DOI 10.4049/jimmunol.0902606-
hcfmusp.relation.referenceQuirce S, 2010, J INVEST ALLERG CLIN, V20, P542-
hcfmusp.relation.referenceRACIOPPI F, 1994, FOOD CHEM TOXICOL, V32, P845, DOI 10.1016/0278-6915(94)90162-7-
hcfmusp.relation.referenceRighettI RF, 2014, RESP PHYSIOL NEUROBI, V192, P134, DOI 10.1016/j.resp.2013.12.012-
hcfmusp.relation.referenceROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504-
hcfmusp.relation.referenceSCHRAUFSTATTER IU, 1990, J CLIN INVEST, V85, P554, DOI 10.1172/JCI114472-
hcfmusp.relation.referenceSchwarze PE, 2013, BIOMED RES INT, DOI 10.1155/2013/685142-
hcfmusp.relation.referenceSeriani R, 2015, ENVIRON TOXICOL, V30, P1297, DOI 10.1002/tox.22000-
hcfmusp.relation.referenceSiracusa A, 2013, ALLERGY, V68, P1532, DOI 10.1111/all.12279-
hcfmusp.relation.referenceTaherali F, 2018, ADV DRUG DELIVER REV, V124, P16, DOI 10.1016/j.addr.2017.10.014-
hcfmusp.relation.referenceTakano H, 2002, AM J RESP CRIT CARE, V165, P1329, DOI 10.1164/rccm20108122-
hcfmusp.relation.referenceTaki F, 2007, CLIN EXP ALLERGY, V37, P599, DOI 10.1111/j.1365-2222.2007.02693.x-
hcfmusp.relation.referenceTarlo SM, 2008, CHEST, V134, p1S, DOI 10.1378/chest.08-0201-
hcfmusp.relation.referenceUpton MN, 2000, BRIT MED J, V321, P88, DOI 10.1136/bmj.321.7253.88-
hcfmusp.relation.referenceVieira RP, 2008, AM J PHYSIOL-LUNG C, V295, pL670, DOI 10.1152/ajplung.00465.2007-
hcfmusp.relation.referenceVieira RP, 2007, AM J RESP CRIT CARE, V176, P871, DOI 10.1164/rccm.200610-1567OC-
hcfmusp.relation.referenceWEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23-
hcfmusp.relation.referenceWeisel CP, 2009, ENVIRON HEALTH PERSP, V117, P500, DOI 10.1289/ehp.11513-
hcfmusp.relation.referenceWhite Carl W, 2010, Proc Am Thorac Soc, V7, P257, DOI 10.1513/pats.201001-008SM-
hcfmusp.relation.referenceWinder C, 2001, ENVIRON RES, V85, P105, DOI 10.1006/enrs.2000.4110-
hcfmusp.relation.referenceWoods CG, 2009, TOXICOL APPL PHARM, V238, P27, DOI 10.1016/j.taap.2009.04.007-
hcfmusp.relation.referenceWoolcock A. J., 1997, CIBA F SYMP, V206, p[122, 157]-
hcfmusp.relation.referenceWoolcock AJ, 1997, CIBA F SYMP, V206, P122-
hcfmusp.relation.referenceZhao HW, 2006, ENVIRON HEALTH PERSP, V114, P1253, DOI 10.1289/ehp.9063-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/20
LIM/20 - Laboratório de Terapêutica Experimental

Artigos e Materiais de Revistas Científicas - LIM/61
LIM/61 - Laboratório de Pesquisa em Cirurgia Torácica

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Files in This Item:
File Description SizeFormat 
art_GENARO_Low_dose_of_chlorine_exposure_exacerbates_nasal_and_2018.PDFpublishedVersion (English)1.94 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.